Tobacco company Altria (NYSE:MO) announced better-than-expected revenue in Q2 CY2025, but sales were flat year on year at $5.29 billion. Its non-GAAP profit of $1.44 per share was 4% above analysts’ consensus estimates.
Is now the time to buy MO? Find out in our full research report (it’s free).
Altria (MO) Q2 CY2025 Highlights:
- Revenue: $5.29 billion vs analyst estimates of $5.20 billion (flat year on year, 1.8% beat)
- Adjusted EPS: $1.44 vs analyst estimates of $1.38 (4% beat)
- Adjusted EBITDA: $3.34 billion vs analyst estimates of $3.27 billion (63.1% margin, 2.2% beat)
- Adjusted EPS guidance for the full year is $5.40 at the midpoint, roughly in line with what analysts were expecting
- Operating Margin: 61.1%, up from 48% in the same quarter last year
- Market Capitalization: $110.3 billion
StockStory’s Take
Altria’s second quarter results were well received by the market, as the company surpassed Wall Street’s revenue and profit expectations despite flat sales year over year. Management attributed the performance to robust growth in the oral tobacco segment, particularly from the on! nicotine pouch brand, which led to substantial profit gains within the segment. CEO William Gifford emphasized the success of targeted marketing efforts and increased brand awareness for on!, noting that “on!’s improving financial performance drove the majority of the oral segment’s substantial profit growth for the quarter.” The company also cited disciplined price management and targeted efforts in the discount cigarette segment as important contributors.
Looking ahead, Altria’s guidance is shaped by ongoing investments in smoke-free products and heightened attention to U.S. regulatory enforcement against illicit e-vapor imports. Management expects continued challenges from inflation and evolving consumer behavior, but remains focused on expanding product options and maintaining profitability. CFO Salvatore Mancuso highlighted that “guidance does contemplate our continued support of our vision and the development of product pipeline within the smoke-free innovative tobacco categories.” Management is also closely monitoring macroeconomic pressures and potential shifts in consumer spending, especially among low-income tobacco users.
Key Insights from Management’s Remarks
Management credited strong oral tobacco growth and disciplined pricing as primary contributors to Q2 performance, while also noting regulatory and supply chain factors shaping the outlook.
- Oral tobacco segment strength: The on! brand drove significant profit growth within the oral tobacco business, benefiting from targeted marketing and increased consumer engagement at events and through digital channels. Management reported a 26.5% year-over-year increase in shipment volume for on! and noted that its brand awareness among adult tobacco users rose by 7 percentage points in the first half of the year.
- Discount brand expansion: The Basic cigarette brand was strategically expanded into about 30,000 additional stores to target price-sensitive consumers while preserving the Marlboro brand’s premium positioning. Management used advanced data analytics to guide this targeted rollout, which resulted in a sequential increase in total retail share for the company’s cigarette portfolio.
- E-vapor regulatory dynamics: Altria highlighted intensified enforcement actions against illicit flavored disposable e-vapor products entering the U.S. market. The company views recent government efforts—such as stricter border controls and FDA warning letters—as positive steps, but continues to advocate for more consistent regulatory action and timely product authorizations.
- Supply chain and tariff impacts: While tariffs have affected costs for certain packaging materials and components, management stated these impacts are not material to the overall business. The supply chain remains flexible, and procurement teams continue to manage costs and inventory effectively.
- Cigar segment resilience: The Middleton brand performed well within the large mass cigar category, maintaining a strong premium position and delivering volume growth despite industry-wide headwinds. Management attributed this to the brand’s established leadership and consistent demand from adult consumers.
Drivers of Future Performance
Management expects future performance to hinge on smoke-free product investments, regulatory enforcement trends, and evolving consumer purchasing behavior.
- Smoke-free product expansion: Altria plans to invest further in its on! nicotine pouch brand and develop a broader portfolio of vapor products, including a modified NJOY ACE device. Management believes these efforts are key to supporting long-term growth and adapting to changing consumer preferences for non-combustible nicotine products.
- Regulatory and enforcement environment: Ongoing government action against illicit e-vapor imports and calls for accelerated FDA product authorizations are expected to shape the competitive landscape. Management is optimistic that stricter enforcement will help level the playing field, but acknowledges uncertainty around the timing and effectiveness of these measures.
- Consumer and macroeconomic pressures: Management is closely watching inflation, fuel prices, and overall consumer confidence, particularly among lower-income tobacco users. The company’s strategy includes targeted pricing and brand efforts to retain consumers within its portfolio during periods of economic strain.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will monitor (1) the pace of regulatory enforcement and its effect on illicit e-vapor market share, (2) the adoption and profitability of new and existing smoke-free products like on! and the planned NJOY relaunch, and (3) consumer behavior in response to inflation and targeted pricing strategies. Progress in FDA product authorizations and the company’s response to evolving regulatory policies will also be key factors.
Altria currently trades at $65.70, up from $59.39 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).
Now Could Be The Perfect Time To Invest In These Stocks
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.